Filtered By:
Condition: Bleeding
Therapy: Dialysis
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 447 results found since Jan 2013.
Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis
CONCLUSIONS: PVE carried significant perioperative risks, and was an independent risk factor of overall mortality.PMID:34085423 | PMC:PMC8176072 | DOI:10.4070/kcj.2020.0448
Source: Korean Circulation Journal - June 4, 2021 Category: Cardiology Authors: Won Kyung Pyo Ho Jin Kim Joon Bum Kim Sung Ho Jung Suk Jung Choo Cheol Hyun Chung Jae Won Lee Source Type: research
STratification risk analysis in OPerative management (STOP score) for drug ‐induced endocarditis
CONCLUSIONDrug ‐related IE is associated with significant morbidity and mortality. An easily‐applied risk stratification score may aid in clinical decision‐making.
Source: Journal of Cardiac Surgery - April 25, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Andreas Habertheuer,
Arnar Geirsson,
Thomas Gleason,
Joseph Woo,
Bryan Whitson,
George J Arnaoutakis,
Pavan Atluri,
Arminder Jassar,
Tsuyoshi Kaneko,
Arman Kilic,
Paul C Tang,
Asher J. Schranz,
Syed Usman Bin Mahmood,
Makoto Mori,
Ibrahim Su Tags: ORIGINAL ARTICLE Source Type: research
Aortic root remodeling with external annuloplasty for acute type A aortic dissection: Midterm results
ConclusionIn a center with expertise in valve ‐sparing procedures, ARREAA is a reasonable option in the surgical management of AAAD in selected patients. This technique stabilizes the aortic annulus and preserves root anatomy for durable outcomes.
Source: Journal of Cardiac Surgery - April 14, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Marie ‐Catherine Morgant,
Ghislain Malapert,
Chloé Bernard,
Aline Laubriet,
Charline Pujos,
Thomas Varin,
Emmanuel Lansac,
Olivier Bouchot Tags: Special Section: Trend & Controversies in Type A Aortic Surgery in 21st Century Source Type: research
Prasugrel and Ticagrelor in Patients with Drug-Eluting Stents and Kidney Failure
CONCLUSIONS: Prasugrel or ticagrelor does not seem to be associated with significant benefits compared with clopidogrel in patients with kidney failure treated with drug-eluting stents.PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2021_04_02_CJN12120720.mp3.PMID:33811128 | DOI:10.2215/CJN.12120720
Source: Clinical Journal of the American Society of Nephrology : CJASN - April 3, 2021 Category: Urology & Nephrology Authors: Thomas A Mavrakanas Omer Kamal David M Charytan Source Type: research
